SEarchiNg BiomarkErs Cerebral Amyloid Angiopathy (SENECA) (SENECA)
SEarchiNg BiomarkErs Cerebral Amyloid Angiopathy (SENECA): Italian Network for the Study of CAA
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
A observational or N/A phase clinical study on Cerebral Amyloid Angiopathy, this trial is actively recruiting participants. The trial is conducted by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta and has accumulated 9 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Dec 2024 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2021 — Jul 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Not Yet Recruiting
-
Jan 2020 — Mar 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
For direct contact, visit the study record on ClinicalTrials.gov .